BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31127888)

  • 21. Extended field radiotherapy with or without chemotherapy in patients with cervical cancer and positive para-aortic lymph nodes: a single institution retrospective review.
    Ng BH; Rozita A; Adlinda A; Lee WC; Wan Zamaniah W
    Asian Pac J Cancer Prev; 2015; 16(9):3827-33. PubMed ID: 25987044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Young age as a prognostic factor in cervical cancer: analysis of population based data from 10,022 cases.
    Meanwell CA; Kelly KA; Wilson S; Roginski C; Woodman C; Griffiths R; Blackledge G
    Br Med J (Clin Res Ed); 1988 Feb; 296(6619):386-91. PubMed ID: 3125911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results and prognostic factors of patients with cervical carcinoma treated with concurrent chemoradiotherapy.
    Reig A; Membrive I; Foro P; Sanz X; Rodríguez N; Lozano J; Lacruz M; Quera J; Fernández-Velilla E; Algara M
    Clin Transl Oncol; 2011 Jul; 13(7):504-8. PubMed ID: 21775278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia.
    Anfinan N; Sait K
    Ann Saudi Med; 2020; 40(1):25-35. PubMed ID: 32026705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age and survival of cervical cancer patients with bone metastasis.
    Nartthanarung A; Thanapprapasr K; Udomsubpayakul U; Thanapprapasr D
    Asian Pac J Cancer Prev; 2014; 15(19):8401-4. PubMed ID: 25339036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (
    Scher N; Castelli J; Depeursinge A; Bourhis J; Prior JO; Herrera FG; Ozsahin M
    Cancer Radiother; 2018 May; 22(3):229-235. PubMed ID: 29650390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
    Hu K; Wang W; Liu X; Meng Q; Zhang F
    Radiat Oncol; 2018 Dec; 13(1):249. PubMed ID: 30558636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of survival rates in patients with lung cancer in west Azerbaijan, the northwest of Iran.
    Abazari M; Gholamnejad M; Roshanaei G; Abazari R; Roosta Y; Mahjub H
    Asian Pac J Cancer Prev; 2015; 16(9):3923-6. PubMed ID: 25987061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of clinical efficacy of three different neoadjuvant approaches (chemotherapy combined vaginal intracavitary irradiation, neoadjuvant chemotherapy alone or radiotherapy) combined with surgery for patients with stage Ib2 and IIa2 cervical cancer.
    Fu JH; Gao Z; Ren CC; Shi YG
    Asian Pac J Cancer Prev; 2013; 14(4):2377-81. PubMed ID: 23725144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
    Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer.
    van Leeuwen CM; Oei AL; Chin KWTK; Crezee J; Bel A; Westermann AM; Buist MR; Franken NAP; Stalpers LJA; Kok HP
    Radiat Oncol; 2017 Apr; 12(1):75. PubMed ID: 28449703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occult invasive cervical cancer found after inadvertent simple hysterectomy: is the ideal management: systematic parametrectomy with or without radiotherapy or radiotherapy only?
    Narducci F; Merlot B; Bresson L; Katdare N; Le Tinier F; Cordoba A; Fournier C; Leblanc E
    Ann Surg Oncol; 2015 Apr; 22(4):1349-52. PubMed ID: 25297903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer.
    Pradhan TS; Duan H; Katsoulakis E; Salame G; Lee YC; Abulafia O
    Int J Gynecol Cancer; 2011 Aug; 21(6):1091-6. PubMed ID: 21738045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution in the management of locally advanced cervical cancer: the experience of Cancer Institute (WIA), Chennai, India.
    Shanta V; Selvaluxmy G; Swaminathan R; Shanthi P
    Asian Pac J Cancer Prev; 2010; 11(4):1091-8. PubMed ID: 21133630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical profile and treatment outcome of collision carcinoma in cervix.
    Shu P; Li R; Xie D; He Y; Wang X; Li Q
    Medicine (Baltimore); 2020 Mar; 99(11):e19131. PubMed ID: 32176038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Glasgow Prognostic Score Determined During Concurrent Chemoradiotherapy Is an Independent Predictor of Survival for Cervical Cancer.
    Nishida T; Nakamura K; Haraga J; Ogawa C; Kusumoto T; Seki N; Masuyama H; Katayama N; Kanazawa S; Hiramatsu Y
    Int J Gynecol Cancer; 2015 Sep; 25(7):1306-14. PubMed ID: 26067860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
    Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
    Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-related survival disparity in stage IB and IIB cervical cancer patients.
    Sakakibara A; Matsui K; Katayama T; Higuchi T; Terakawa K; Konishi I
    J Obstet Gynaecol Res; 2019 Mar; 45(3):686-694. PubMed ID: 30623525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.